Document Detail


Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
MedLine Citation:
PMID:  6394127     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effectiveness and safety of two antibiotic regimens, netilmicin-ticarcillin (NT) and tobramycin-ticarcillin (TT), were compared in a prospective, randomized, blind-evaluator study involving 60 elderly patients with serious systemic infections. Fifty-three patients were evaluated for treatment effectiveness; 25 (93%) of 27 patients in the NT group and 24 (92%) of 26 patients in the TT group had complete clinical resolution or improvement of their infections. There were two clinical failures in each group. Bacteriological responses were comparable in both treatment groups, with 87% (58/67) of the pathogens eliminated from patients in the NT group and 83% (59/71) eliminated from the patients in the TT group. The elimination rate for Pseudomonas aeruginosa, the organism most frequently isolated, was 88% (14/16) in the NT group and 77% (10/13) in the TT group. The differences between response rates of the treatment groups were not statistically significant. Auditory toxicity, detected by pure tone audiometry, was observed in two of the 24 patients treated with TT and in none of the patients treated with NT. Dizziness or vertigo, possibly resulting from aminoglycoside administration, occurred in one of the 29 patients given NT and in four of the 31 patients given TT. Nephrotoxicity, detected by serial serum creatinine determinations, developed in none of the patients in the NT group and in five of the 31 patients in the TT group, the difference being statistically significant (P = 0.05). The results of this study indicate that NT and TT are comparable in efficacy and that NT is less likely than TT to cause nephrotoxicity or disturbances in eighth cranial nerve function.
Authors:
W Jansen; A Schwarz
Related Documents :
15342307 - N-terminal pro-brain natriuretic peptide reflects pulmonary capillary leakage in patien...
20947817 - Increased serum n-terminal pro-b-type natriuretic peptide levels in patients with media...
10640797 - Failure of thrombin generation markers to triage patients presenting with chest pain.
21319597 - Angiotensin ii receptor type 1 1166 a/c and angiotensin converting enzyme i/d gene poly...
2618577 - Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic ne...
9798137 - Hyperprolactinemia: an inductor of neoplastic changes in endometrium? a report of two c...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Clinical therapeutics     Volume:  7     ISSN:  0149-2918     ISO Abbreviation:  Clin Ther     Publication Date:  1984  
Date Detail:
Created Date:  1985-03-21     Completed Date:  1985-03-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7706726     Medline TA:  Clin Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  112-20     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Bacterial Infections / blood,  drug therapy*
Clinical Trials as Topic
Double-Blind Method
Drug Therapy, Combination
Female
Gentamicins / therapeutic use*
Hearing Tests
Humans
Kidney Function Tests
Liver Function Tests
Male
Netilmicin / administration & dosage,  adverse effects,  therapeutic use*
Penicillins / therapeutic use*
Random Allocation
Ticarcillin / administration & dosage,  adverse effects,  therapeutic use*
Tobramycin / administration & dosage,  adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Gentamicins; 0/Penicillins; 32986-56-4/Tobramycin; 34787-01-4/Ticarcillin; 56391-56-1/Netilmicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Considerations in the use of nude mice for cancer research.
Next Document:  Patient selection and the assessment of blood pressure in clinical trials.